Major differences dynamics primary secondary progressive multiple sclerosis patients primary secondary progressive multiple sclerosis MS major differences pattern extent abnormality cerebral magnetic resonance imaging MRI groups present study patients age sex duration disease disability serial gadolinium diethylenetriaminepentaacetic acid-enhanced MRI period patients secondary progressive group total new lesions time lesions patient year Enhancement edge lesions contrast new lesions primary progressive group lesions patient year difference degree clinical deterioration groups period findings difference dynamics disease activity forms progressive MS relation inflammatory component lesions important implications selection patients monitoring disease activity therapeutic trials 